PCM
RPTP

Prelude Capital Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Prelude Capital Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,500
Closed -$25K – 2489
2014
Q1 		$25K Hold
2,500
– – ﹤0.01% 1628
2013
Q4 		$33K Buy
+2,500
New +$34.4K 0.01% 1256

Prelude Capital Management's RPTP Position: Q4 2016 in Review

Prelude Capital Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 171,958 shares — an estimated $1.54M sold.

Prelude Capital Management first reported a position in RPTP in Q2 2013 and held it in 9 quarters. The position peaked at $1.54M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Prelude Capital Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Prelude Capital Management sold 171,958 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.54M.
  • Prelude Capital Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 9 quarters.
  • Prelude Capital Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.54M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Prelude Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.